Plus Therapeutics (PSTV) Current Leases (2019 - 2026)
Plus Therapeutics (PSTV) reported Current Leases of $58000.0 for Q1 2026, up 45.0% year-over-year from $40000.0 in Q1 2025, and up 3.57% quarter-over-quarter from $56000.0 in Q4 2025.
Plus Therapeutics (PSTV) Current Leases (2019 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 8 years of Current Leases data on file, last reported at $58000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $58000.0, up 45.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $58000.0 (up 45.0% YoY), and the FY2025 annual result was $56000.0, up 27.27% from the prior year.
- Current Leases climbed to $58000.0 in Q1 2026 per PSTV's latest filing, from $56000.0 in the prior quarter.
- Over five years, Current Leases peaked at $120000.0 in Q4 2023 and troughed at $21000.0 in Q3 2025.
- A 5-year average of $82882.4 and a median of $104000.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2025 and 2026: Current Leases sank 69.12% in 2025, then jumped 45.0% in 2026.
- A 5-year view of Current Leases shows it stood at $110000.0 in 2022, then grew by 9.09% to $120000.0 in 2023, then tumbled by 63.33% to $44000.0 in 2024, then advanced by 27.27% to $56000.0 in 2025, then climbed by 3.57% to $58000.0 in 2026.
- Business Quant data shows PSTV's Current Leases at $58000.0 in Q1 2026, $56000.0 in Q4 2025, and $21000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | 58,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Sep 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 110,000.00 |
| Mar 31, 2023 | 107,000.00 |
| Dec 31, 2022 | 110,000.00 |
| Sep 30, 2022 | 107,000.00 |
| Jun 30, 2022 | 104,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Dec 31, 2021 | 111,000.00 |
| Sep 30, 2021 | 106,000.00 |
| Jun 30, 2021 | 127,000.00 |